Address: Bayer House
Strawberry Hill
Newbury
Berkshire
RG14 1JA
UK,United Kingdom
Tel: +44 (0)1635 563000
Web: http://www.bayer.co.uk/scripts/pages/en/index.php
The Bayer UK/Ireland Region is part of the global concern Bayer AG, based in Leverkusen, Germany, with almost 108,600 employees worldwide and a yearly turnover in excess of 32 billion Euros across its three main business areas – HealthCare, MaterialScience and CropScience.
In Europe, where 44% of the company’s turnover resides, the UK/Ireland region is placed fifth, has 1,249 employees and three main operating companies, whose activities mirror Bayer’s operations globally.
Bayer has been trading in the UK/Ireland region since Friedrich Bayer first sold his dyestuffs here in 1871. Early business was handled through the offices of engineering company JM Steel, then through Bayer’s own operations, based in Manchester, then Surrey and, latterly, in Newbury, Berkshire.
Bayer focuses strongly on the key goals of improving profit performance and cost efficiency, leading to top line growth and, ultimately, added value for all its stakeholders – customers, suppliers, shareholders, employees and its local communities.
The company has CropScience production units in the UK/Ireland region, making it a major exporter. There are also importers, distributors and sales and marketing specialists.
Bayer has over 5,000 products, found in virtually every area of human activity. One thing they all have in common is that they are derived from, or related to chemistry. Another characteristic is that many of them are unrecognisable to the man in the street, as they are often raw materials that go to make a consumer product. There are well known exceptions, such as Alka Seltzer, Berocca, Baby Bio and Levitra, which enjoy a high profile.
The company is equally proud to be associated with some of the region’s – indeed the world’s – biggest brands, which use Bayer’s materials in the manufacture of their own world-beating products.
Within the global trend of increased economic pressures on the pharmaceutical industry, there has been a recent focus on growth in emerging markets. In this context, where does this leave…
A British success story, Clinigen Group provides companies with services in portfolio and product lifecycle management on a global basis. Its CEO, Shaun Chilton, talks to us about the value…
Having recently joined the UK operations of AstraZeneca after a varied international career, Laurent Abuaf shares his vision of the UK as a life sciences reference market and his take…
Heading Accord Healthcare’s European, Middle East and North African operations, James Burt highlights the rapid growth the company has achieved within the region and how it has reached an impressive…
Promoting the UK’s capital in times of Brexit, Laura Citron, CEO at London & Partners, the international promotional agency of the Mayor of London, stresses the critical importance life sciences…
Erik Nordkamp, managing director of Pfizer UK, has been confirmed as the new president of the Association of the British Pharmaceutical Industry (ABPI). With UK life sciences still uncertain as…
Craig Wallace established the UK affiliate of Santen, the Japanese ophthalmology company, in 2014. Wallace describes the journey Santen has been on so far in the UK, as well as…
Britain, home of the discovery of the world’s first ever vaccine, has long been championing a pharma sub-segment forecast to reach a global market value of USD 49.27 billion by…
Thomas Bo Bjorn Klee, managing director of Lundbeck UK and Ireland, describes the global restructuring program Lundbeck initiated two years ago to ensure value creation, build on unique strengths and…
Having recently been able to present positive data for their lead technology IMCgp100 in uveal melanoma at the American Society of Clinical Oncology (ASCO), Immunocore looks at its future as…
Erik Nordkamp, managing director of Pfizer UK shares his thoughts on the future of healthcare and the role that Pfizer and the UK can play in shaping it. He explains…
Stewart Pearce, managing director of Otsuka UK and Ireland since 2017 discloses how he built up a leadership team fit for the Otsuka of 2023 and highlights what he appreciates…
As the UK extracts itself from the European Union, key figures from the country’s life sciences sector are split on the implications of Brexit for their industry. “The UK pharmaceutical…
See our Cookie Privacy Policy Here
